Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?
Publication
, Journal Article
Wolf, M
Published in: Semin Dial
2011
Duke Scholars
Published In
Semin Dial
DOI
EISSN
1525-139X
Publication Date
2011
Volume
24
Issue
4
Start / End Page
428 / 430
Location
United States
Related Subject Headings
- Vitamins
- Vitamin D
- Urology & Nephrology
- Parathyroid Hormone
- Kidney Failure, Chronic
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wolf, M. (2011). Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Semin Dial, 24(4), 428–430. https://doi.org/10.1111/j.1525-139X.2011.00914.x
Wolf, Myles. “Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?” Semin Dial 24, no. 4 (2011): 428–30. https://doi.org/10.1111/j.1525-139X.2011.00914.x.
Wolf M. Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Semin Dial. 2011;24(4):428–30.
Wolf, Myles. “Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?” Semin Dial, vol. 24, no. 4, 2011, pp. 428–30. Pubmed, doi:10.1111/j.1525-139X.2011.00914.x.
Wolf M. Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Semin Dial. 2011;24(4):428–430.
Published In
Semin Dial
DOI
EISSN
1525-139X
Publication Date
2011
Volume
24
Issue
4
Start / End Page
428 / 430
Location
United States
Related Subject Headings
- Vitamins
- Vitamin D
- Urology & Nephrology
- Parathyroid Hormone
- Kidney Failure, Chronic
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences